SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-21-238541
Filing Date
2021-08-06
Accepted
2021-08-06 07:46:17
Documents
6
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d209830d20fa.htm 20-F/A 29935
2 EX-12.1 d209830dex121.htm EX-12.1 4470
3 EX-12.2 d209830dex122.htm EX-12.2 4511
4 EX-15.1 d209830dex151.htm EX-15.1 3151
5 EX-15.2 d209830dex152.htm EX-15.2 4032
6 GRAPHIC g209830g25e73.jpg GRAPHIC 3285
  Complete submission text file 0001193125-21-238541.txt   51811
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38475 | Film No.: 211150589
SIC: 2834 Pharmaceutical Preparations